Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-11-18 MEDP / Medpace Holdings, Inc. 4 Troendle August J. S - Sale D 590.84 -7,191
2025-11-18 ONMD / OneMedNet Corporation 4 Green Aaron S - Sale D 1.2006 -61,555
2025-11-17 MEDP / Medpace Holdings, Inc. 4 Troendle August J. S - Sale D 591 -6,047
2025-11-17 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 104.36 -278
2025-11-17 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 64.25 278
2025-11-14 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. S - Sale D 591.85 -6,472
2025-11-14 MEDP / Medpace Holdings, Inc. 4 Troendle August J. S - Sale D 595.26 -14,747
2025-11-14 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 54.99 6,472
2025-11-13 MEDP / Medpace Holdings, Inc. 4 Troendle August J. S - Sale D 601.37 -5,128
2025-11-12 MEDP / Medpace Holdings, Inc. 4 Troendle August J. S - Sale D 603.23 -5,312
2025-11-11 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E S - Sale D 605 -18,000
2025-11-10 INCY / Incyte Corporation 4 Hoppenot Herve S - Sale D 105.46 -187,500
2025-11-07 OABI / OmniAb, Inc. 4 HIGGINS JOHN L P - Purchase D 1.38 41,038
2025-11-06 OABI / OmniAb, Inc. 4 HIGGINS JOHN L P - Purchase D 1.41 36,223
2025-11-06 CRL / Charles River Laboratories International, Inc. 4 Knell Michael Gunnar A - Award D 170.88 2,926
2025-11-05 INCY / Incyte Corporation 4 Stein Steven H S - Sale D 102.20 -5,233
2025-11-05 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J S - Sale D 595.66 -21,503
2025-11-05 INCY / Incyte Corporation 4 Stein Steven H M - Exercise D 95.76 1,044
2025-11-05 INCY / Incyte Corporation 4 Stein Steven H M - Exercise D 95.76 2,995
2025-11-05 INCY / Incyte Corporation 4 Stein Steven H M - Exercise D 83.83 1,194
2025-11-04 INCY / Incyte Corporation 4 Denton Sheila A. S - Sale D 101.36 -598
2025-11-04 INCY / Incyte Corporation 4 Denton Sheila A. M - Exercise D 58.06 598
2025-11-03 INCY / Incyte Corporation 4 Heeson Lee S - Sale D 94.02 -3,074
2025-11-03 NOTV / Inotiv, Inc. 4 Neff R Matthew S - Sale D 1.2434 -2,000
2025-11-01 OABI / OmniAb, Inc. 4 Love Steven M - Exercise D 13,333
2025-11-01 OABI / OmniAb, Inc. 4 Bertozzi Carolyn R M - Exercise D 17,769
2025-10-30 MEDP / Medpace Holdings, Inc. 4 DAVENPORT FRED B JR S - Sale D 581.88 -5,972
2025-10-30 MEDP / Medpace Holdings, Inc. 4 DAVENPORT FRED B JR M - Exercise D 54.99 6,472
2025-10-29 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI S - Sale D 221.97 -3,973
2025-10-29 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI S - Sale D 218.32 -7,315
2025-10-29 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI S - Sale D 217.58 -800
2025-10-29 IQV / IQVIA Holdings Inc. 4 Sherbet Eric S - Sale D 219.70 -4,000
2025-10-29 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI S - Sale D 221.31 -26,128
2025-10-29 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI S - Sale D 220.11 -4,600
2025-10-29 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI S - Sale D 219.29 -13,741
2025-10-29 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J S - Sale D 585 -3,568
2025-10-29 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J M - Exercise D 166.73 3,568
2025-10-29 IQV / IQVIA Holdings Inc. 4 Sherbet Eric M - Exercise D 131.82 10,000
2025-10-29 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI M - Exercise D 59.90 77,592
2025-10-29 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI D - Sale to Issuer D 220.96 -21,035
2025-10-29 IQV / IQVIA Holdings Inc. 4 Sherbet Eric D - Sale to Issuer D 219.72 -6,000
2025-10-27 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J S - Sale D 605.12 -19,460
2025-10-27 MEDP / Medpace Holdings, Inc. 4 EWALD STEPHEN P S - Sale D 598.85 -15,230
2025-10-27 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E S - Sale D 605.01 -2,000
2025-10-27 MEDP / Medpace Holdings, Inc. 4 EWALD STEPHEN P M - Exercise D 166.73 18,230
2025-10-27 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J M - Exercise D 166.73 19,460
2025-10-24 NOTV / Inotiv, Inc. 4 Neff R Matthew M - Exercise D 1.94 10,000
2025-10-22 ONMD / OneMedNet Corporation 4 Green Aaron S - Sale D 2.2345 -64,767
2025-10-17 BNBX / BNB Plus Corp. 4 SHAMASH YACOV A A - Award D 22,511
2025-10-17 BNBX / BNB Plus Corp. 4 Ferguson Elizabeth M. A - Award D 22,511
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)